All research

CASE STUDY · PRIMARY RESEARCH · 5 MIN

The bids that lied

A Queensland home was listed in June at a price anchored on premium-pocket sales a street away. Within weeks, the campaign told a clear story: buyers were capping their offers around $1.15 million, roughly $200,000 below the ask. The property sat. Weeks became months. The bids stayed low, the days on market climbed, and by every visible signal the market had spoken. The home, everyone agreed, was worth what buyers were offering.

In September, it sold for $1,315,000.

“The offers on a failed campaign understate the asset's value. The early bids are the campaign's scar tissue. The eventual sale is the evidence.”

The sequence deserves a slow read, because almost everyone reads it backwards. The vendor's original anchor, high in the $1.3 millions, was treated as the mistake. The buyers' $1.15 million ceiling was treated as the truth. Three months of low bids looked like the market delivering a verdict. What it was actually delivering was a lesson in how failed campaigns behave. A listing that launches at the wrong price accumulates days on market, and days on market accumulate stigma. Each week unsold signals desperation to the next buyer, and desperate campaigns attract opportunistic bids. The offers were not measuring the home. They were measuring the campaign's exhaustion.

“The market was never pricing the house at $1.15 million. It was pricing three months of stale listing.”

None of this was visible to the homeowner at the time, and that is the point. From inside a campaign, a low bid feels like information. It arrives on letterhead, through an agent, with numbers attached. It is very hard to see scar tissue for what it is when you are the one bleeding. This case became Rule 49 of our specification: the offers on a stale campaign are evidence about the campaign, the eventual sale is evidence about the home, and the two must never be confused. It is a rule we paid full price to learn, because we got it wrong in both directions ourselves. Before the sale, we assessed the home at a midpoint of $1.19 million, a local agent with two years inside that exact corridor expected $1.25 million at most, and the market cleared it $65,000 above his ceiling and $125,000 above the bid stack. The bids lied to all of us.

“Every party who touched this sale underestimated it: the model, the insider, the bid stack. Only the calendar was right in the end.”

The practical cost of the original mispricing was not the $200,000 gap the bids implied. It was the calendar. Three months of holding, three months of stale-listing stigma to unwind, three months of a family living inside an unsold decision. That is the honest arithmetic of pricing a home wrong: you rarely lose the gap between your price and the market. You lose the time it takes to find out what the market was actually saying.

If you are selling, the lesson has a sharp edge. Never let a failed campaign's bids set your expectations, and never let them set your next price. The evidence you want is not what tired buyers offered in month three. It is what a fresh buyer eventually paid.

Sources

ALURA validation log, open case 21, closed 17 Sep 2026: 21 Looby Crescent, listed June 2026, high $1.3M anchor, buyer offers capped ~$1.15M, sold $1,315,000

ALURA assessment log: committed pre-sale band $1.095M to $1.29M, midpoint $1.19M (outcome logged publicly, 17 Sep)

Wake County listing study, 2024: 14% of listings expire annually

REDX expired-listing dataset (2.7M leads): 44.4% re-list rate with new agents